ABSTRACT
El control de calidad citoplasmático es esencial en el mantenimiento de la viabilidad celular, y particularmente, de las células β pancreáticas, debido a su gran capacidad de síntesis proteica. En este contexto, juega un papel esencial la activación de un proceso fisiológico denominado autofagia, conduciendo a la eliminación de agregados proteicos y/o orgánulos, induciendo la atenuación del estrés de retículo celular. El complejo formado por las proteínas hamartina y tuberina (TSC1-TSC2) ha emergido como un núcleo de integración de la señalización de factores de crecimiento y del estado energético celular. Este complejo funciona como un inhibidor de la actividad de la vía del complejo mecanicístico diana de la rapamicina (mTORC1) y un activador de la autofagia. En este proyecto queremos profundizar en el estudio de nuevos mecanismos moleculares de regulación de TSC2, así como sobre dichos mecanismos de control de calidad citoplasmático, autofagia y mitofagia. Proponemos que el estado de acetilación en lisinas de TSC2, mediado por la actividad desacetilasa de la sirtuina1 (SIRT1), modula la estabilidad y actividad de la misma afectando a la homeostasis celular (AU)
Cytoplasmic quality control is essential in maintaining cell viability, and articularly, β pancreatic cells, due to its huge protein synthesis capacity. In this context, it is important the activation of a physiological process called autophagy, in order to eliminate protein aggregates and damaged organelles, resulting in a reduction in the reticulum cell stress. The complex formed by hamartin and tuberin (TSC1-TSC2) has emerged as a central signal, energy status and nutrient-integrating node within the cell. This complex negatively regulates the mechanistic target of rapamycin complex 1 (mTORC1), and activates autophagy. In this proyect we aimed to further investigate new molecular mechanisms of TSC2 regulation, aswell as cytoplasmic quality control, autophagy and mitophagy ones. We propose that the TSC2 acetylation status, mediated by the deacetylation activity of sirtuin1 (SIRT1), modulates its stability and protein activity, affecting cell homeostasis
Subject(s)
Humans , Diabetes Mellitus, Type 2/drug therapy , Multiprotein Complexes/pharmacology , Diabetes Mellitus, Type 2/physiopathology , Autophagy , Sirtuin 1/pharmacokinetics , Homeostasis , Disease ProgressionABSTRACT
Hepatitis C virus (HCV) core protein stimulates many signaling pathways related to apoptosis inhibition resulting in hepatocellular carcinoma (HCC). It has been reported that sirt1 is involved in regulating apoptosis; therefore, we investigated the influence of HCV core protein on sirt1 expression and apoptosis in human HepG2 cells. Our study showed that HCV core protein inhibited apoptosis of HepG2 cells as well as caspase-3 expression and activity (P < 0.05). At the same time, sirt1 expression was increased at both the mRNA (P < 0.05) and protein (P < 0.05) levels. Furthermore, apoptosis inhibition was reversed when sirt1 was knocked down (P < 0.05). Our study provides further evidence that the sirt1-p53-Bax signaling pathway plays an important role in regulating the suppression of cell apoptosis induced by HCV core protein.
Subject(s)
Apoptosis/drug effects , Hep G2 Cells/virology , Hepacivirus/physiology , Sirtuin 1/metabolism , Tumor Suppressor Protein p53/metabolism , Viral Core Proteins/biosynthesis , Viral Core Proteins/metabolism , bcl-2-Associated X Protein/metabolism , Base Sequence , Carcinoma, Hepatocellular/metabolism , Carcinoma, Hepatocellular/virology , Gene Knockdown Techniques , Hep G2 Cells/cytology , Hepacivirus/metabolism , Humans , Liver Neoplasms/metabolism , Liver Neoplasms/virology , Molecular Sequence Data , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , RNA, Small Interfering/administration & dosage , RNA, Small Interfering/genetics , Signal Transduction , Sirtuin 1/pharmacokinetics , Viral Core Proteins/geneticsABSTRACT
Sirtuins, silent information regulator 2 (Sir 2) proteins, belong to the family of NAD+-dependent enzymes with deacetylase or mono-ADP-ribosyltransferase activity. These enzymes are responsible for processes of DNA repair or recombination, chromosomal stability and gene transcription. In mammals, sirtuins occur in seven varieties, from 1 to 7 (SIRT1SIRT7), differing among themselves with location. SIRT1, the best known variety, exerts its effects on proteins via NAD+ coenzymes, being thus associated with cellular energetic metabolism and the redox state. Its deficits are, among others, concomitant with stressful situations and associated with pathophysiologies of many medical conditions, including diabetes mellitus, cardiovascular diseases, neurodegenerative syndromes and kidney diseases. In kidney disorders, it promotes (stimulates) the survival of cells in an affected kidney by modulating their responses to various stress stimuli, takes part in arterial blood pressure control, protects against cellular apoptosis in renal tubules by catalase induction and triggers autophagy. More and more available in vitro and in vivo data indicate SIRT1 activity to be oriented, among others, towards nephroprotection. Thus, SIRT1 may become a novel element in the therapy of age-related renal diseases, including diabetic nephropathy (AU)
